{"name":"Xizang Haisco Pharmaceutical Co., Ltd","slug":"xizang-haisco-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"HSK21542 tablet","genericName":"HSK21542 tablet","slug":"hsk21542-tablet","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"HSK21542 tablet","genericName":"HSK21542 tablet","slug":"hsk21542-tablet","phase":"marketed","mechanism":"HSK21542 is a small-molecule inhibitor that targets specific kinases involved in cellular signaling pathways.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9WeC13a05KY0dRNlRIaGFvY2tVX29CUGRkR0xlQnpzOG1lX1Z4czRzbG5fQ005V3RmSFktTjFFWnZWTGZqX1ZxZ2ZIZk1NTWJEeVhr?oc=5","date":"2017-03-02","type":"pipeline","source":"Forbes","summary":"Zheng Wei - Forbes","headline":"Zheng Wei","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5CcnF5ZS1udWNoWDhJb29mU1VYZ0VGRDM4RVdYUFo0b1ZRUWRBY1diODFJUElUSlN2Mm9NZ0lGS3BUbzNyazhrOUZicG1nNm1Qb1NLUmpR?oc=5","date":"2016-07-27","type":"pipeline","source":"Forbes","summary":"Wang Junmin - Forbes","headline":"Wang Junmin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxOTEROczgxTUVwSmhEV0NMSnFlWFIyYTZYMndnd0trd0NYNUhmd3F5bm5JS0lHa0kwOEExQnVJQzRCYzdYMDZQWV96SFhpdWdEZHEzZlVac3NiSTFqdV9UeTI0VzhaYTFqQ3F0TlRINWFJeXBuZTgxV0p3azBQcVFnaEliS0hxWjNDTk9pUFgzUUVQTzlCdXJET0dYbFhsUFJKZUx2SWR1MVZaX3g1QXlsU2YwZ2sxMDlKTGozRWZsQm9sejQ?oc=5","date":"2012-12-21","type":"pipeline","source":"NextInsight","summary":"FAN XIULIAN: Haisco Pharma Mogul Has Remedy For Riches - NextInsight","headline":"FAN XIULIAN: Haisco Pharma Mogul Has Remedy For Riches","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}